5,5′-substituted indirubin-3′-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity

导出原文传递

翻译打印收藏纠错

作者： Choi, S.-J. ^[1] ; Lee, J.-E. ^[2] ; Jeong, S.-Y. ^[3] ; Im, I. ^[4] ; Lee, S.-D. ^[5] ; Lee, E.-J. ; Lee, S.K. ; Kwon, S.-M. ; Ahn, S.-G. ; Yoon, J.-H. ; Han, S.-Y. ; Kim, J.-I. ; Kim, Y.-C.

作者单位： Pharmacology Research Center, Korea Research Institute of Chemical Technology, Daejon 305-600, South Korea ^[1] Division of Drug Discovery, Anygen Co., Ltd., Gwangju 500-712, South Korea ^[2] College of Pharmacy, Ewha Womans University, Seoul 120-759, South Korea ^[3] Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, South Korea ^[4] Department of Pathology, School of Dentistry, Chosun University, Gwangju 501-759, South Korea ^[5]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of Medicinal Chemistry

2010年53卷9期

3696-3706页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

5,5′-substituted indirubin-3′-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

5,5′-substituted indirubin-3′-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

检索历史清除